-
Australia's new Ghost Shark submarines grow some 'teeth'
-
China's third-quarter growth narrowly beats forecasts
-
'I call it a bribe': Pennsylvania residents spurn $10,000 data center checks
-
Asian stocks start week on back foot, tracking tech-led Wall St losses
-
In a former US steel city, ordinary people struggle to get by
-
China growth narrowly beats forecasts
-
'Liar,' 'clown': Lula and Bolsonaro spar in Brazil poll debate
-
Faith and fury: Texas Senate rivals offer contrasting visions
-
Record El Nino? Depends who's counting
-
Women await justice for police killings in Brazil
-
On the front line of ocean conservation off Portugal's Madeira
-
The painstaking task of cataloguing the world's species
-
Wembanyama targets title breakthrough as NBA season tips off
-
Nations seek reset at UN talks as nature goals off track
-
With LeBron on board it's title or bust for Philly fans
-
Rubio seeks to strengthen US foothold in Central Asia
-
One year after Louvre heist, where are the missing jewels?
-
LeBron joins 76ers to chase one more NBA title at age 41
-
Knicks face tall task in NBA championship repeat bid
-
Rays one win from World Series return after downing Guardians
-
Warriors' Curry 'fine' after limping out of practice - Kerr
-
BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 19
-
Caledonia Mining Corporation Plc: Notification of Relevant Change To Significant Shareholder
-
Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement
-
Kings' Ben Simmons tears Achilles in training
-
Zelensky speaks to US envoys as Trump lashes out
-
Lula, Bolsonaro set for first debate showdown in bitter election race
-
'Surprise package' Lazio crush Juve to keep pace with Serie A leaders Inter
-
Mbappe hits two as Real Madrid rout Sevilla
-
China growth expected to miss official target in third quarter
-
Browns edge Ravens for division lead, Texans beat Jags
-
Lazio crush Juventus to move level with Serie A leaders Inter
-
Lyon go top of Ligue 1 as Monaco fall to first defeat of the season
-
Leeds draw feels like 'fresh start' for Man Utd's Carrick
-
Venezuela opposition alliance reaffirms Nobel laureate Machado as leader
-
Macron denounces 'unbridled' violence as France hit by new clashes
-
'Street Fighter' wins N. America box office, buzzy doc stuns in 2nd
-
Hurzeler lauds 'hard worker' Gomez after Brighton goal from halfway line
-
NFL: Paris game to go ahead despite protests in France
-
Toulouse hold off Exeter, Northampton save English Champions Cup blushes
-
Arteta hails Arsenal 'finishers' after Madueke fells Forest
-
Arsenal snatch late win to keep pressure on Man City as Man Utd held
-
Trump backs ally Netanyahu ahead of Israel's tight election
-
Arsenal strike late to keep pressure on Man City as Man Utd held
-
Madueke strikes late as below-par Arsenal sink Forest
-
Four soldiers dead, dozens injured in fire at Canada military base
-
Second day of street clashes in Milan
-
Ton-up Agha helps Pakistan down Sri Lanka in tri-series opener
-
Dupont's Toulouse hold off Exeter as English Champions Cup woes continue
Nitches Inc. (OTC:NICH) Launches NutraVeri, a Product Readiness Platform for Dietary Supplement Concepts
Platform provides founders with readiness scoring, formula analysis, and manufacturing pathway evaluation before production commitments are made.
MIAMI, FL / ACCESS Newswire / June 16, 2026 / Nitches Inc. (OTCID:NICH) today announced the commercial launch of NutraVeri, a product readiness platform designed to help founders evaluate, refine, and prepare dietary supplement concepts for potential manufacturing and commercialization.
The dietary supplement market represents one of the largest consumer health categories in the world, yet moving a concept from idea to production often requires specialized expertise, regulatory awareness, formulation knowledge, and manufacturing relationships that can be difficult for independent founders to access. NutraVeri was developed to help bridge that gap.
NutraVeri allows users to submit a supplement concept, including intended ingredients, dosage levels, product category, target outcomes, and proposed claims. The platform generates a NutraVeri Score across six readiness dimensions: Formula Strength, Ingredient Evidence, Claim Safety, Label Readiness, Manufacturing Readiness, and Market Fit.
Users receive an initial readiness assessment at no cost. Depending on the needs of the project, the platform can also provide a written analysis report, a portable product readiness record, optional human formula review, and evaluation for potential introduction to manufacturing resources.
NutraVeri utilizes publicly available scientific and regulatory reference sources, including FDA labeling resources, warning letter archives, dietary supplement databases, Generally Recognized as Safe (GRAS) references, and FTC advertising guidance. The platform evaluates proposed formulations and claims against available reference data to help identify potential areas requiring further review.
NutraVeri provides informational product readiness intelligence only. NutraVeri Scores, reports, and recommendations do not constitute legal, regulatory, medical, or compliance advice and should not be interpreted as certification, approval, validation, or endorsement of any product.
The platform is intended for independent founders, wellness entrepreneurs, creators, emerging brands, and established supplement companies seeking additional diligence prior to product development and manufacturing discussions.
"For many founders, the biggest challenge is not having an idea-it is understanding whether that idea is ready to move forward," said John Morgan, Chief Executive Officer of Nitches Inc. "NutraVeri was designed to bring structure, transparency, and practical guidance to the earliest stages of product development. Our goal is to help founders identify opportunities, recognize potential challenges, and make more informed decisions before committing substantial time and capital to a concept."
Consumer interest in dietary supplements continues to expand, while creator-driven brands and direct-to-consumer health products have become increasingly common. NutraVeri is designed to provide a structured starting point for founders seeking to evaluate concepts before entering formulation, labeling, or manufacturing processes.
The platform is now publicly available at nutraveri.com, where users can receive an initial NutraVeri readiness score at no cost.
About Nitches Inc. (OTCID:NICH)
Nitches Inc. (OTCID:NICH) is a publicly traded technology company focused on developing and operating digital platforms that help consumers, founders, and businesses make more informed decisions. The Company seeks to identify markets where expertise, regulatory complexity, and fragmented information create barriers to entry and then build scalable software solutions designed to improve transparency and accessibility.
NutraVeri is Nitches' flagship platform, created to help founders evaluate, refine, and prepare dietary supplement concepts before committing significant resources to formulation, manufacturing, and commercialization. By combining scientific reference data, regulatory intelligence, and product readiness analysis into a unified workflow, NutraVeri is designed to provide users with a structured path from idea to market evaluation while helping identify potential risks and opportunities early in the development process.
Media Contact
John Morgan
Chief Executive Officer
Nitches Inc.
[email protected]
www.nutraveri.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the launch, functionality, anticipated adoption, future development, and commercial prospects of the NutraVeri platform. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those described herein. Forward-looking statements are not guarantees of future performance. NutraVeri Scores, reports, analyses, and related outputs are informational tools only and do not certify regulatory compliance, approval, safety, efficacy, manufacturing acceptance, or commercial success. Dietary supplement products are not approved by the U.S. Food and Drug Administration prior to marketing. Nitches Inc. undertakes no obligation to update any forward-looking statements except as required by applicable law. Investors are encouraged to review the Company's public filings and disclosures for additional information regarding risks and uncertainties.
SOURCE: Nitches, Inc.
View the original press release on ACCESS Newswire
D.Kaufman--AMWN